Market Overview:
The global diabetes therapy and drug delivery market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in diabetes therapies and drug delivery devices, and rising demand for minimally invasive therapies. Inhalable insulin is the fastest-growing type segment of the global diabetes therapy and drug delivery market. This segment is expected to grow at a CAGR of 11.5% from 2018 to 2030 due to the increasing demand for needle-free insulin administration methods. Oral insulin is another fast-growing type segment of this market, owing to its advantages over injectable insulin such as ease of use and patient compliance. The oral insulin segment is expected grow at a CAGR of 11% from 2018to 2030 . The diagnostic/clinics application segment dominates the global diabetes therapy and drug delivery market with a shareof more than 50%.
Product Definition:
Diabetes therapy and drug delivery is a very important field of study because it helps to treat diabetes, which is a disease that affects millions of people all over the world. By understanding how to best deliver drugs to those with diabetes and learning more about the best therapies for treating the disease, researchers can help improve the quality of life for people living with diabetes.
Inhalable Insulin:
Inhalable insulin is a type of insulin that can be delivered through the respiratory tract by using nebulizers and inhalers. The drug delivery system has been designed in such a way that it helps in improving the blood glucose level of patients suffering from diabetes mellitus. This drug delivery system also helps to reduce the frequency of hospital visits, reduces stress for patients and caregivers, and improves quality life for people with diabetes.
Oral Insulin:
Oral insulin is a hormone that helps in the regulation of blood sugar levels. It works by helping the pancreas to produce more insulin or by enhancing the action of already produced insulin. The two types of oral insulins are rapid-acting and long-acting. Long-acting type is usually administered to patients suffering from diabetes for whom conventional methods of injecting insulin have not been effective enough, as it takes around 8 hours for this drug to take effect.
Application Insights:
On the basis of application, the global diabetes therapy and drug delivery market is segmented into diagnostics/clinics, intensive care units (ICUs), home healthcare and others. The diagnostics/clinics segment held a major share in 2017 due to increasing prevalence of diabetes coupled with rising demand for point-of-care testing devices.
The home healthcare segment is expected to witness significant growth over the forecast period due to increasing awareness about CGM systems among patients as well as health professionals. Moreover, artificial pancreas would also be classified under this segment owing to its usage in treating type 1 and type 2 diabetes mellitus at home without hospitalization or other medical facilities.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing cases of diabetes and growing awareness about these therapies. In addition, presence of key players such as Abbott, Novo Nordisk A/S, and Sanofi are also contributing towards growth in this region. For instance, Novo Nordisk has commercialized DPP-4 asthma drug Duetrial since 2015 which is indicated for treatment of adult asthma symptoms including breathlessness and wheezing caused by allergies or other triggers (pollens).
Asia Pacific is anticipated to be the fastest-growing regional market over the forecast period owing to rising diabetic population along with increasing healthcare expenditure in countries like India & China. Moreover, availability of effective treatments at low costs will drive demand for inhalable insulin products such as Nebulizer System that help control diabetes complications resulting from lack of insulin production by pancreas cells or inadequate response by existing beta cells in this region.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is primarily due to the changing lifestyle and dietary habits of people across the world. As a result, there is a growing demand for therapies and drugs that can help in the treatment and management of diabetes.
- Advances in drug delivery technology: Drug delivery technology is evolving rapidly, with new technologies being developed to improve the efficacy and safety of therapies for diabetes patients. This is resulting in increased uptake of novel drug delivery systems by pharmaceutical companies, which is driving growth in this market segment.
- Growing focus on self-management: There has been a growing focus on self-management among diabetics in recent years, with patients taking greater responsibility for their own health care needs. This has led to an increase in demand for devices and therapies that can help diabetics manage their condition effectively on their own without relying on others for assistance or support.
Scope Of The Report
Report Attributes
Report Details
Report Title
Diabetes Therapy and Drug Delivery Market Research Report
By Type
Inhalable Insulin, Oral Insulin, Insulin Patches, CGM Systems, Artificial Pancreas
By Application
Diagnostic/Clinics, ICUs, Home Healthcare
By Companies
Abbott Laboratories, Medtronic, Sanofi, Novo Nordisk, MannKind, Enteris BioPharma, Dexcom, Senseonics Holding, Medtech, Johnson & Johnson, Synertech, Zosano Pharma, Relmada Therapeutics, Eli Lilly, Transdermal Specialties
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
190
Number of Tables & Figures
133
Customization Available
Yes, the report can be customized as per your need.
Global Diabetes Therapy and Drug Delivery Market Report Segments:
The global Diabetes Therapy and Drug Delivery market is segmented on the basis of:
Types
Inhalable Insulin, Oral Insulin, Insulin Patches, CGM Systems, Artificial Pancreas
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostic/Clinics, ICUs, Home Healthcare
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Medtronic
- Sanofi
- Novo Nordisk
- MannKind
- Enteris BioPharma
- Dexcom
- Senseonics Holding
- Medtech
- Johnson & Johnson
- Synertech
- Zosano Pharma
- Relmada Therapeutics
- Eli Lilly
- Transdermal Specialties
Highlights of The Diabetes Therapy and Drug Delivery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Inhalable Insulin
- Oral Insulin
- Insulin Patches
- CGM Systems
- Artificial Pancreas
- By Application:
- Diagnostic/Clinics
- ICUs
- Home Healthcare
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diabetes Therapy and Drug Delivery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diabetes therapy and drug delivery is the process of delivering medications to patients with diabetes. This can include both oral medications and insulin injections.
Some of the key players operating in the diabetes therapy and drug delivery market are Abbott Laboratories, Medtronic, Sanofi, Novo Nordisk, MannKind, Enteris BioPharma, Dexcom, Senseonics Holding, Medtech, Johnson & Johnson, Synertech, Zosano Pharma, Relmada Therapeutics, Eli Lilly, Transdermal Specialties.
The diabetes therapy and drug delivery market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diabetes Therapy and Drug Delivery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Diabetes Therapy and Drug Delivery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Diabetes Therapy and Drug Delivery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Diabetes Therapy and Drug Delivery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Diabetes Therapy and Drug Delivery Market Size & Forecast, 2020-2028
4.5.1 Diabetes Therapy and Drug Delivery Market Size and Y-o-Y Growth
4.5.2 Diabetes Therapy and Drug Delivery Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Inhalable Insulin
5.2.2 Oral Insulin
5.2.3 Insulin Patches
5.2.4 CGM Systems
5.2.5 Artificial Pancreas
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Diagnostic/Clinics
6.2.2 ICUs
6.2.3 Home Healthcare
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diabetes Therapy and Drug Delivery Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diabetes Therapy and Drug Delivery Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Inhalable Insulin
9.6.2 Oral Insulin
9.6.3 Insulin Patches
9.6.4 CGM Systems
9.6.5 Artificial Pancreas
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Diagnostic/Clinics
9.10.2 ICUs
9.10.3 Home Healthcare
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Inhalable Insulin
10.6.2 Oral Insulin
10.6.3 Insulin Patches
10.6.4 CGM Systems
10.6.5 Artificial Pancreas
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Diagnostic/Clinics
10.10.2 ICUs
10.10.3 Home Healthcare
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Inhalable Insulin
11.6.2 Oral Insulin
11.6.3 Insulin Patches
11.6.4 CGM Systems
11.6.5 Artificial Pancreas
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Diagnostic/Clinics
11.10.2 ICUs
11.10.3 Home Healthcare
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Inhalable Insulin
12.6.2 Oral Insulin
12.6.3 Insulin Patches
12.6.4 CGM Systems
12.6.5 Artificial Pancreas
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Diagnostic/Clinics
12.10.2 ICUs
12.10.3 Home Healthcare
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Inhalable Insulin
13.6.2 Oral Insulin
13.6.3 Insulin Patches
13.6.4 CGM Systems
13.6.5 Artificial Pancreas
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Diagnostic/Clinics
13.10.2 ICUs
13.10.3 Home Healthcare
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diabetes Therapy and Drug Delivery Market: Competitive Dashboard
14.2 Global Diabetes Therapy and Drug Delivery Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Medtronic
14.3.3 Sanofi
14.3.4 Novo Nordisk
14.3.5 MannKind
14.3.6 Enteris BioPharma
14.3.7 Dexcom
14.3.8 Senseonics Holding
14.3.9 Medtech
14.3.10 Johnson & Johnson
14.3.11 Synertech
14.3.12 Zosano Pharma
14.3.13 Relmada Therapeutics
14.3.14 Eli Lilly
14.3.15 Transdermal Specialties
